Ticker >

Lactose India share price

Lactose (India) Ltd.

BSE: 524202 SECTOR: Pharmaceuticals & Drugs  9173   7   0

165.40
+7.85 (4.98%)
BSE: Today, 12:50 PM

Price Summary

Today's High

₹ 165.4

Today's Low

₹ 165.4

52 Week High

₹ 157.55

52 Week Low

₹ 39.25

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

208.22 Cr.

Enterprise Value

246.13 Cr.

No. of Shares

1.26 Cr.

P/E

39.42

P/B

4.63

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  35.71

CASH

0.92 Cr.

DEBT

38.82 Cr.

Promoter Holding

53.66 %

EPS (TTM)

₹  4.2

Sales Growth

43.23%

ROE

3.03 %

ROCE

9.35%

Profit Growth

-50.69 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year43.23%
3 Year18%
5 Year16.17%

Profit Growth

1 Year-50.69%
3 Year156.05%
5 Year23.81%

ROE%

1 Year3.03%
3 Year0.82%
5 Year0.98%

ROCE %

1 Year9.35%
3 Year7.46%
5 Year7.87%

Debt/Equity

0.9572

Price to Cash Flow

25.84

Interest Cover Ratio

1.24264364769037

CFO/PAT (5 Yr. Avg.)

15.7162100572239

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 53.66 26.06
Sep 2023 53.77 26.01
Jun 2023 53.79 0
Mar 2023 53.79 48.34
Dec 2022 53.79 48.34
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 156.052296444905% for the Past 3 years.
  • The company has shown a good revenue growth of 17.997113083177% for the Past 3 years.
  • The Company has been maintaining an effective average operating margins of 21.7397389675193% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -18.4873147759631 days.
  • The company has a good cash flow management; CFO/PAT stands at 15.7162100572239.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.51848024833039.

 Limitations

  • Company has a poor ROE of 0.822773354238493% over the past 3 years.
  • The company is trading at a high PE of 39.42.
  • Promoter pledging is high as 26.06%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 17.02 25.99 27.47 24.43 32.6
Total Expenditure 14.28 21.91 23.7 21.03 26.87
Operating Profit 2.73 4.08 3.77 3.4 5.73
Other Income 0.16 0.15 0.28 0.26 0.28
Interest 1.55 1.93 1.55 1.31 1.21
Depreciation 1.17 1.19 1.19 1.2 1.2
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.17 1.12 1.31 1.14 3.6
Tax 0.02 0.23 0.35 0.33 0.97
Profit After Tax 0.15 0.89 0.96 0.81 2.63
Adjusted EPS (Rs) 0.12 0.71 0.76 0.64 2.09

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 40.61 40.05 34.96 45.94 65.8
Total Expenditure 31 30.78 28.74 33.68 54.34
Operating Profit 9.61 9.27 6.22 12.26 11.46
Other Income 0.42 0.3 0.31 0.58 0.73
Interest 5.35 5.56 5.45 5.12 6.04
Depreciation 3.6 3.91 4.36 4.56 4.69
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.07 0.1 -3.27 3.17 1.46
Tax 0.35 0.03 -0.79 0.72 0.26
Net Profit 0.72 0.07 -2.48 2.45 1.21
Adjusted EPS (Rs.) 0.71 0.07 -2.17 1.95 0.96

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 10.19 10.19 11.44 12.59 12.59
Total Reserves 24.06 24.1 23.65 26.7 27.97
Borrowings 31.5 34.42 39.26 34.25 33.04
Other N/C liabilities 3.81 3.89 2.36 1.77 1.61
Current liabilities 12.11 11.41 11.63 14.91 26.57
Total Liabilities 81.67 84 88.34 90.22 101.78
Assets
Net Block 60.39 61.82 59.47 59.22 56.07
Capital WIP 1.48 0.23 3.52 0 0
Intangible WIP 0 0 0 0 0
Investments 0.08 0.07 0.68 0.74 0
Loans & Advances 2.03 1.38 4.37 7 7.82
Other N/C Assets 0 0.69 0.61 0.51 0.39
Current Assets 17.69 19.81 19.7 22.75 37.5
Total Assets 81.67 84 88.34 90.22 101.78
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 1.07 0.1 -3.27 3.17 1.46
Adjustment 8.66 9.31 9.85 9.6 10.79
Changes in Assets & Liabilities -4.12 -2.04 -4.44 -4.36 -4.16
Tax Paid -0.68 0.04 0.03 0.07 -0.04
Operating Cash Flow 4.93 7.41 2.17 8.47 8.06
Investing Cash Flow -1.8 -2.88 -6.18 -0.56 -1.02
Financing Cash Flow -5.12 -3.57 4.52 -8.14 -8.38
Net Cash Flow -1.99 0.96 0.51 -0.24 -1.34

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 53.79 53.79 53.79 53.77 53.66
atul maheshwari 10.81 10.81 - 10.81 10.81
atul maheshwari 0.40 - 10.81 - 0.40
madhusha lifecare pvt. lt... 4.59 4.59 4.59 4.58 4.58
pushpa suraj maheshwari 0.90 0.90 0.90 0.90 0.90
sangita maheshwari 12.23 12.23 12.23 12.23 30.73
shyamsunder bhorilal tosh... 16.45 16.45 16.45 16.45 5.96
yashvardhan maheshwari 0.28 0.28 0.28 0.28 0.28
atul maheshwari . - 0.40 - 0.40 -
madhubala toshniwal 8.13 8.13 8.13 8.13 -
atul maheshwari huf - - 0.40 - -
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 46.21 46.21 46.21 46.23 46.34
gyaneshwar multitrade pri... 4.27 4.27 4.27 4.23 4.24
mahendra girdharilal wadh... - - - 1.18 1.18
mahendra girdharilal 1.18 1.18 1.18 - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Lactose India Stock Price Analysis and Quick Research Report. Is Lactose India an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Lactose India and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Lactose India cash from the operating activity was Rs 8.0572 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Lactose India has a Debt to Equity ratio of 0.9572 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Lactose India , the EPS growth was -50.6933032046015 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Lactose India has OPM of 17.4110094336612 % which is a good sign for profitability.
     
  • ROE: Lactose India have a poor ROE of 3.02759325498212 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Lactose India is Rs 165.4. One can use valuation calculators of ticker to know if Lactose India share price is undervalued or overvalued.
Last Updated on:
Brief about Lactose India
X